Scottish Business Briefing – Tuesday 17 December

WELCOME to scotsman.com’s Scottish Business Briefing. Every morning we bring you a comprehensive round-up of all news affecting business in Scotland today.
BrewDog: Bank investment shunned. Picture: Neil Hanna/TSPLBrewDog: Bank investment shunned. Picture: Neil Hanna/TSPL
BrewDog: Bank investment shunned. Picture: Neil Hanna/TSPL

FINANCE

RBS saves £320m fee as £8bn support removed

TAXPAYER support for Royal Bank of Scotland (RBS) was formally reduced by a further £8 billion yesterday after the removal of a back-up scheme a year earlier than planned. (Scotsman)

MANAGEMENT

Creditfix top of the league as Flynn plans for more growth

CREDITFIX, a Glasgow-based insolvency specialist bought by Irish entrepreneur Pearse Flynn in 2007 when it turned over £1 million, has become Scotland’s market leader and number five in the UK with the takeover of a Manchester rival. (Herald)

ENERGY

Aggreko leaps £350m as it reveals new deals

Hide Ad
Hide Ad

SCOTTISH temporary power supplier Aggreko has enjoyed a near-£350 million surge in its stock market worth, after telling the City its 2013 results would likely exceed expectations and unveiling contracts for next year’s Commonwealth Games and football World Cup. (Herald)

FOOD, DRINK & AGRICULTURE

Beer fans finance BrewDog growth plans

A controversial north-east brewery has raised more than £4million from its customers after shunning investment from banks. (Press & Journal)

(http://www.scotsman.com/business/food-drink-agriculture|Read all today’s food, drink and agriculture news from scotsman.com|Click here}

TRANSPORT & INDUSTRY

Property firm Dominvs in £30m Aberdeen hotel plan

AN INVESTMENT company set up by Euro Car Parts founder Sukhpal Singh Ahluwalia yesterday unveiled £30 million plans to build two hotels in Aberdeen and revealed it is also in talks to buy a site in Edinburgh. (Scotsman)

MEDIA, TECH & LEISURE

Angel’s fall fuels biotech’s return to market

A SCOTTISH life sciences company that rose from the ashes of collapsed Angel Biotechnology is preparing to return to the stock market and take over a Californian peer. (Scotsman)

Related topics: